Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

BUY
$0.42 - $0.72 $1,481 - $2,539
3,527 Added 0.23%
1,509,393 $950,000
Q3 2023

Nov 13, 2023

BUY
$0.6 - $1.53 $6,739 - $17,184
11,232 Added 0.75%
1,505,866 $903,000
Q2 2023

Aug 11, 2023

BUY
$1.05 - $1.63 $52,356 - $81,276
49,863 Added 3.45%
1,494,634 $1.69 Million
Q1 2023

May 12, 2023

BUY
$1.2 - $2.73 $1.38 Million - $3.14 Million
1,151,666 Added 392.92%
1,444,771 $1.95 Million
Q4 2022

Feb 13, 2023

SELL
$1.71 - $3.61 $5,099 - $10,765
-2,982 Reduced 1.01%
293,105 $545,000
Q3 2022

Nov 14, 2022

SELL
$1.9 - $8.63 $29,685 - $134,835
-15,624 Reduced 5.01%
296,087 $728,000
Q2 2022

Aug 15, 2022

BUY
$2.13 - $9.01 $103,462 - $437,651
48,574 Added 18.46%
311,711 $761,000
Q1 2022

May 16, 2022

BUY
$6.28 - $15.59 $1.11 Million - $2.76 Million
176,807 Added 204.8%
263,137 $2.1 Million
Q4 2021

Feb 14, 2022

BUY
$14.7 - $28.67 $3,630 - $7,081
247 Added 0.29%
86,330 $1.32 Million
Q3 2021

Nov 15, 2021

BUY
$24.31 - $33.6 $283,114 - $391,305
11,646 Added 15.65%
86,083 $2.45 Million
Q2 2021

Aug 17, 2021

BUY
$26.09 - $40.4 $902,400 - $1.4 Million
34,588 Added 86.8%
74,437 $2.51 Million
Q1 2021

May 17, 2021

BUY
$33.06 - $56.93 $228,345 - $393,215
6,907 Added 20.97%
39,849 $1.52 Million
Q4 2020

Feb 16, 2021

SELL
$39.09 - $57.4 $16.8 Million - $24.6 Million
-428,700 Reduced 92.86%
32,942 $1.38 Million
Q3 2020

Nov 16, 2020

BUY
$28.43 - $44.67 $6.38 Million - $10 Million
224,272 Added 94.48%
461,642 $20 Million
Q2 2020

Aug 14, 2020

BUY
$11.71 - $30.29 $2.61 Million - $6.76 Million
223,128 Added 1566.69%
237,370 $7.19 Million
Q1 2020

May 15, 2020

BUY
$7.64 - $27.5 $108,808 - $391,655
14,242 New
14,242 $194,000
Q2 2019

Aug 14, 2019

SELL
$17.37 - $26.27 $3.95 Million - $5.97 Million
-227,166 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$10.65 - $25.75 $2.42 Million - $5.85 Million
227,166 New
227,166 $5.32 Million

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.